Literature DB >> 21983632

Critical involvement of extracellular ATP acting on P2RX7 purinergic receptors in photoreceptor cell death.

Shoji Notomi1, Toshio Hisatomi, Takaaki Kanemaru, Atsunobu Takeda, Yasuhiro Ikeda, Hiroshi Enaida, Guido Kroemer, Tatsuro Ishibashi.   

Abstract

Stressed cells release ATP, which participates in neurodegenerative processes through the specific ligation of P2RX7 purinergic receptors. Here, we demonstrate that extracellular ATP and the more specific P2RX7 agonist, 2'- and 3'-O-(4-benzoylbenzoyl)-ATP, both induce photoreceptor cell death when added to primary retinal cell cultures or when injected into the eyes from wild-type mice, but not into the eyes from P2RX7(-/-) mice. Photoreceptor cell death was accompanied by the activation of caspase-8 and -9, translocation of apoptosis-inducing factor from mitochondria to nuclei, and TUNEL-detectable chromatin fragmentation. All hallmarks of photoreceptor apoptosis were prevented by premedication or co-application of Brilliant Blue G, a selective P2RX7 antagonist that is already approved for the staining of internal limiting membranes during ocular surgery. ATP release is up-regulated by nutrient starvation in primary retinal cell cultures and seems to be an initializing event that triggers primary and/or secondary cell death via the positive feedback loop on P2RX7. Our results encourage the potential application of Brilliant Blue G as a novel neuroprotective agent in retinal diseases or similar neurodegenerative pathologies linked to excessive extracellular ATP.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21983632      PMCID: PMC3260798          DOI: 10.1016/j.ajpath.2011.08.035

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  61 in total

1.  Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide.

Authors:  L C Denlinger; P L Fisette; J A Sommer; J J Watters; U Prabhu; G R Dubyak; R A Proctor; P J Bertics
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

2.  Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems.

Authors:  S A Deuchars; L Atkinson; R E Brooke; H Musa; C J Milligan; T F Batten; N J Buckley; S H Parson; J Deuchars
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

3.  P2X7 receptor inhibition improves recovery after spinal cord injury.

Authors:  Xiaohai Wang; Gregory Arcuino; Takahiro Takano; Jane Lin; Wei Guo Peng; Pinglan Wan; Pingjia Li; Qiwu Xu; Qing Song Liu; Steven A Goldman; Maiken Nedergaard
Journal:  Nat Med       Date:  2004-07-18       Impact factor: 53.440

4.  Chromovitrectomy: a new field in vitreoretinal surgery.

Authors:  Eduardo B Rodrigues; Carsten H Meyer; Peter Kroll
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-10       Impact factor: 3.117

5.  FAS-mediated apoptosis and its relation to intrinsic pathway activation in an experimental model of retinal detachment.

Authors:  David N Zacks; Qiong-Duan Zheng; Ying Han; Rita Bakhru; Joan W Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-12       Impact factor: 4.799

6.  ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site.

Authors:  Sahil Adriouch; Peter Bannas; Nicole Schwarz; Ralf Fliegert; Andreas H Guse; Michel Seman; Friedrich Haag; Friedrich Koch-Nolte
Journal:  FASEB J       Date:  2007-10-10       Impact factor: 5.191

Review 7.  P2X receptors as cell-surface ATP sensors in health and disease.

Authors:  Baljit S Khakh; R Alan North
Journal:  Nature       Date:  2006-08-03       Impact factor: 49.962

8.  Visual field defects after uneventful vitrectomy for epiretinal membrane with indocyanine green-assisted internal limiting membrane peeling.

Authors:  Akinori Uemura; Shigeru Kanda; Yushi Sakamoto; Hazuki Kita
Journal:  Am J Ophthalmol       Date:  2003-08       Impact factor: 5.258

9.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme.

Authors:  J Yuan; S Shaham; S Ledoux; H M Ellis; H R Horvitz
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

10.  Oxygen-glucose deprivation induces ATP release via maxi-anion channels in astrocytes.

Authors:  Hong-Tao Liu; Ravshan Z Sabirov; Yasunobu Okada
Journal:  Purinergic Signal       Date:  2007-09-12       Impact factor: 3.765

View more
  33 in total

Review 1.  Photoreceptor cell death and rescue in retinal detachment and degenerations.

Authors:  Yusuke Murakami; Shoji Notomi; Toshio Hisatomi; Toru Nakazawa; Tatsuro Ishibashi; Joan W Miller; Demetrios G Vavvas
Journal:  Prog Retin Eye Res       Date:  2013-08-28       Impact factor: 21.198

Review 2.  Purines in the eye: recent evidence for the physiological and pathological role of purines in the RPE, retinal neurons, astrocytes, Müller cells, lens, trabecular meshwork, cornea and lacrimal gland.

Authors:  Julie Sanderson; Darlene A Dartt; Vickery Trinkaus-Randall; Jesus Pintor; Mortimer M Civan; Nicholas A Delamere; Erica L Fletcher; Thomas E Salt; Antje Grosche; Claire H Mitchell
Journal:  Exp Eye Res       Date:  2014-08-20       Impact factor: 3.467

3.  Deregulation of ocular nucleotide homeostasis in patients with diabetic retinopathy.

Authors:  Sirpa Loukovaara; Jouko Sandholm; Kristiina Aalto; Janne Liukkonen; Sirpa Jalkanen; Gennady G Yegutkin
Journal:  J Mol Med (Berl)       Date:  2016-09-16       Impact factor: 4.599

4.  Lack of the P2X7 receptor protects against AMD-like defects and microparticle accumulation in a chronic oxidative stress-induced mouse model of AMD.

Authors:  Kyle A Carver; C M Lin; Catherine Bowes Rickman; Dongli Yang
Journal:  Biochem Biophys Res Commun       Date:  2016-10-31       Impact factor: 3.575

5.  Macular peeling-induced retinal damage: clinical and histopathological evaluation after using different dyes.

Authors:  Mario R Romano; Gennaro Ilardi; Mariantonia Ferrara; Gilda Cennamo; Barbara Parolini; Cesare Mariotti; Stefania Staibano; Giovanni Cennamo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-08       Impact factor: 3.117

6.  Efficacy of novel selective NLRP3 inhibitors in human and murine retinal pigment epithelial cells.

Authors:  Luping Wang; Sarah Schmidt; Petra P Larsen; Johanna H Meyer; William R Roush; Eicke Latz; Frank G Holz; Tim U Krohne
Journal:  J Mol Med (Berl)       Date:  2019-02-10       Impact factor: 4.599

7.  Crucial role of P2X7 receptor for effector T cell activation in experimental autoimmune uveitis.

Authors:  Atsunobu Takeda; Hisakata Yamada; Eiichi Hasegawa; Mitsuru Arima; Shoji Notomi; Sayaka Myojin; Takeru Yoshimura; Toshio Hisatomi; Hiroshi Enaida; Ryoji Yanai; Kazuhiro Kimura; Tatsuro Ishibashi; Koh-Hei Sonoda
Journal:  Jpn J Ophthalmol       Date:  2018-03-23       Impact factor: 2.447

8.  The regulatory roles of apoptosis-inducing factor in the formation and regression processes of ocular neovascularization.

Authors:  Toshio Hisatomi; Shintaro Nakao; Yusuke Murakami; Kousuke Noda; Toru Nakazawa; Shoji Notomi; Edward Connolly; Haicheng She; Lama Almulki; Yasuhiro Ito; Demetrios G Vavvas; Tatsuro Ishibashi; Joan W Miller
Journal:  Am J Pathol       Date:  2012-05-19       Impact factor: 4.307

9.  Comparisons of cone electroretinograms after indocyanine green-, brilliant blue G-, or triamcinolone acetonide-assisted macular hole surgery.

Authors:  Shigeki Machida; Yoshiharu Toba; Tomoharu Nishimura; Takayuki Ohzeki; Ken-ichi Murai; Daijiro Kurosaka
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-02       Impact factor: 3.117

Review 10.  Purinergic signaling in the retina: From development to disease.

Authors:  Ana Lucia Marques Ventura; Alexandre Dos Santos-Rodrigues; Claire H Mitchell; Maria Paula Faillace
Journal:  Brain Res Bull       Date:  2018-11-17       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.